ENGN

enGene TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

ENGN vs peer average

95/100

ENGN vs. peer average (A vs. D)

Grade spread

B 2 · C 2 · D 3 · F 4

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

CGON is the first available peer comparator.

Closest clinical comparator because cretostimogene targets BCG-unresponsive NMIBC with CIS; most useful for assessing the efficacy and durability threshold, not balance-sheet valuation.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerCGONCG Oncology

ENGN

enGene Therapeutics

CGON

CG Oncology

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs CGON

ENGN / CGON

Grade Position

Above peers

ENGN vs. peer average (A vs. D)

95/100

Momentum

CGON

Value

ENGN

Sentiment

ENGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ENGN

40/100

60/100

60/100

BGM Group Ltd Class A Common

20/100

CPIX

Cumberland Pharmaceuticals Inc Common

80/100

CGON is the first peer returned for this comparison set.